Sandler Yael 4

What Happened Yael Sandler, Chief Financial Officer of Cybra, Inc. (CYAB), was granted 101,071 derivative shares on March 27, 2026. The filing lists these as an award/grant of derivative securities (replacement options); no per-share price or immediate cash value is disclosed. This is an equity award (compensation/retention), not an open-market purchase or sale.

Key Details

• Transaction date: March 27, 2026. Filing date: March 31, 2026 (filed on time under Form 4 rules).
• Amount: 101,071 derivative shares reported as a grant/award. Price/consideration: N/A (derivative instrument).
• Shares owned after transaction: Not specified in the provided excerpt.
• Footnote highlights:
  • These are "Replacement Options" under the Cyabra Inc. 2026 Omnibus Equity Incentive Plan with a vesting schedule that began July 2, 2024: 25% vests after 12 months, then equal quarterly vesting (1/12 of remaining) thereafter, fully vested by the schedule set in the footnote.
  • The award was issued in connection with Cybra’s business combination with Trailblazer Merger Corporation I.
  • Prior Cyabra options (aggregate 28,000 ordinary shares) were converted into these Replacement Options on the same terms as the originals.
• No indication this was an exercise or immediate sale; it's a grant of derivative securities (options).

Context

• These are equity awards (options/replacement options). They do not represent immediate stock purchases or sales and will only affect share ownership if/when vested and exercised.
• Because the award stems from the company’s merger and option-replacement mechanics, it’s largely a compensation/continuity item rather than a signal of an insider buying or selling stock.